Search by Drug Name or NDC

    NDC 76282-0681-46 ALENDRONATE SODIUM 35 mg/1 Details

    ALENDRONATE SODIUM 35 mg/1

    ALENDRONATE SODIUM is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by EXELAN PHARMACEUTICALS INC.. The primary component is ALENDRONATE SODIUM.

    Product Information

    NDC 76282-0681
    Product ID 76282-681_2012c7a8-8aa7-4c18-a8c3-fe74d74ac873
    Associated GPIs 30042010100335
    GCN Sequence Number 047381
    GCN Sequence Number Description alendronate sodium TABLET 35 MG ORAL
    HIC3 P4L
    HIC3 Description BONE RESORPTION INHIBITORS
    GCN 12389
    HICL Sequence Number 010124
    HICL Sequence Number Description ALENDRONATE SODIUM
    Brand/Generic Generic
    Proprietary Name ALENDRONATE SODIUM
    Proprietary Name Suffix n/a
    Non-Proprietary Name Alendronate sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 35
    Active Ingredient Units mg/1
    Substance Name ALENDRONATE SODIUM
    Labeler Name EXELAN PHARMACEUTICALS INC.
    Pharmaceutical Class Bisphosphonate [EPC], Diphosphonates [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA076768
    Listing Certified Through 2024-12-31

    Package

    NDC 76282-0681-46 (76282068146)

    NDC Package Code 76282-681-46
    Billing NDC 76282068146
    Package 3 BLISTER PACK in 1 CARTON (76282-681-46) / 4 TABLET in 1 BLISTER PACK (76282-681-45)
    Marketing Start Date 2021-02-02
    NDC Exclude Flag N
    Pricing Information N/A